# Atara Biotherapeutics, Inc. (ATRA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ATRA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 516.0K | $ -4.15M | $ -3.07M | N/A | $ -37.31M |
| 2025 | $ 123.66M | $ 33.47M | $ -52.16M | $ 52.80M | $ -38.50M |
| 2024 | $ 135.53M | $ -89.77M | $ -72.49M | $ 43.83M | $ -97.28M |
| 2023 | $ 9.27M | $ -298.56M | $ -209.98M | $ 57.87M | $ -99.23M |
| 2022 | $ 71.02M | $ -255.04M | $ -306.78M | $ 71.70M | $ 126.64M |
| 2021 | $ 24.18M | $ -404.31M | $ -274.70M | $ 28.27M | $ 279.61M |
| 2020 | $ 0 | $ -390.61M | $ -236.02M | $ 15.03M | $ 462.34M |
| 2019 | $ 0 | $ -2.84B | $ -311.53M | $ 15.72M | $ 290.78M |
| 2018 | $ 0 | $ -3.05B | $ -284.87M | $ 0 | $ 338.86M |
| 2017 | $ 0 | $ -1.61B | $ -145.13M | $ 0 | $ 177.86M |
| 2016 | $ 0 | $ -1.09B | $ -86.74M | $ 0 | $ 253.74M |
| 2015 | $ 0 | $ -803.41M | $ -52.58M | $ 0 | $ 315.10M |
| 2014 | $ 0 | $ -395.73M | $ -23.56M | $ 0 | $ 103.18M |
| 2013 | $ 0 | $ -124.77M | $ -8.49M | $ 0 | $ -11.02M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | -1.54 |
| Current Ratio | 2.16 |

## Other views

- [Metrics](https://sponda.capital/en/ATRA.md)
- [Charts](https://sponda.capital/en/ATRA/charts.md)
- [Compare](https://sponda.capital/en/ATRA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.